Market Tracker

10/21 3:57pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

10.08
Real-Time Quote
 -0.02 / -0.20%
Today’s Change
2.97
Today|||52-Week Range
12.45
+158.46%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close10.10
Today’s open10.17
Day’s range9.94 - 10.20
Volume354,223
Average volume (3 months)428,540
Market cap$385.0M
Dividend yield--
Data as of 3:41pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-58.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+699.98%
P/E ratioNM
Price/Sales650.44
Price/Book8.65

Competitors

 Today’s
change
Today’s
% change
VTLVital Therapies Inc+0.68+4.19%
SCLNSciClone Pharmaceuti...+0.25+3.23%
IMDZImmune Design Corp+2.51+10.74%
ZFGNZafgen Inc+0.12+0.69%
Data as of 3:52pm ET, 10/21/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$152.4K
Annual profit (last year)-$20.5M
Net profit margin-13,438.82%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
Chief Financial Officer, Treasurer &
Secretary
Sean A. Power
Corporate headquarters
New York, New York

Forecasts